| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.3 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |